Oncology

FDA expands use of Xalkori

On March 11, the Food and Drug Administration (FDA) approved Xalkori (crizotinib) to treat people with metastatic non-small cell lung cancer (NSCLC) whose tumors…

Understanding radiation dermatitis

According to the National Cancer Institute, an estimated 1.6 million new cases of cancer will have been diagnosed in the United States in 2015.…
Research

How to evaluate qualitative research

Editor’s note: This article is a follow-up to “Understanding qualitative research,” published in the July issue of American Nurse Today. Have you ever told…

FDA expands use of Xalkori

On March 11, the Food and Drug Administration (FDA) approved Xalkori (crizotinib) to treat people with metastatic non-small cell lung cancer (NSCLC)…

Understanding radiation dermatitis

According to the National Cancer Institute, an estimated 1.6 million new cases of cancer will have been diagnosed in the United States…
Research

How to evaluate qualitative research

Editor’s note: This article is a follow-up to “Understanding qualitative research,” published in the July issue of American Nurse Today. Have you…

Poll

Julie NyhusGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.